-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Biodesix, Raises Price Target to $40

Benzinga·10/13/2026 15:58:25
Listen to the news
TD Cowen analyst Dan Brennan maintains Biodesix (NASDAQ:BDSX) with a Buy and raises the price target from $30 to $40.